{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:33:36Z","timestamp":1788554016468,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Thrombocytopenia following Perceval aortic valve replacement has been described previously with variable outcome. Studies have lacked a robust analysis of platelet fluctuation and factors affecting it. We aimed to statistically describe the trend in thrombocyte variability as compared with conventional aortic valve replacement, and to assess predictors as well as impact on associated outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>One hundred consecutive patients with first-time Perceval were retrospectively compared to 219 patients after Perimount Magna Ease valve replacement. The primary outcome was the serial thrombocyte count on day 0\u20136. Generalized estimating equations were used to analyse the data using fixed-effect models: for the effect of the post-operative day on platelet count, and random-effect models estimating both time-variant (platelets) and time in-variant variables (valve type, age, LV function, pre-op platelet level).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Perceval patients were older (72\u2009\u00b1\u20091 vs 68\u2009\u00b1\u20091\u00a0years, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) with higher NYHA status (3(2\u20133) vs 2(1\u20132), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Mean platelet count in the sutureless group was lowest on day 2 (91.9\u2009\u00b1\u200931.6 vs 121.7\u2009\u00b1\u200953.8\u2009\u00d7\u200910<jats:sup>3<\/jats:sup>\u00a0\u00b5l<jats:sup>\u22121<\/jats:sup>), and lower on day 4 (97.9\u2009\u00b1\u200944) and 6 (110.6\u2009\u00b1\u200961) compared to the conventional group (157.2\u2009\u00b1\u200960 and 181.7\u2009\u00b1\u200979) but did not result in a higher number of transfusions, bleeding or longer hospital stay (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Reduced platelet count was a strong predictor of red cell transfusion in the conventional (<jats:italic>p<\/jats:italic>\u2009=\u20090.016), but not in the sutureless group (<jats:italic>p<\/jats:italic>\u2009=\u20090.457). Age (Coef -1.025, 95%CI-1.649\u2014-0.401, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and CPB-time (Coef 0.186, 95%CI-0.371\u2014-0.001, <jats:italic>p<\/jats:italic>\u2009=\u20090.048) were predictors for lower platelet levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Considering the older patient profile treated with Perceval, postoperative thrombocytopenia does not impact on outcome in terms of transfusions, complications or hospital stay.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-024-02755-2","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:33:32Z","timestamp":1713242012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thrombocytopenia after sutureless and standard stented aortic valve replacement: a retrospective analysis of risk factors, clinical course, and early outcome"],"prefix":"10.1186","volume":"19","author":[{"given":"Alicja","family":"Zientara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousuf","family":"Salmasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Milan-Chhatrisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Quarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Asimakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"issue":"1","key":"2755_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jtcvs.2019.07.046","volume":"160","author":"P Stegmeier","year":"2020","unstructured":"Stegmeier P, Schl\u00f6micher M, Stiegler H, Strauch JT, Bechtel JFM. Thrombocytopenia after implantation of the Perceval S aortic bioprosthesis. J Thorac Cardiovasc Surg. 2020;160(1):61\u20138.e8.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"2755_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.21470\/1678-9741-2017-0157","volume":"33","author":"SS Mujtaba","year":"2018","unstructured":"Mujtaba SS, Ledingham S, Shah AR, Schueler S, Clark S, Pillay T. Thrombocytopenia after aortic valve replacement: comparison between sutureless perceval s valve and perimount magna ease bioprosthesis. Braz J Cardiovasc Surg. 2018;33(2):169\u201375.","journal-title":"Braz J Cardiovasc Surg"},{"issue":"6","key":"2755_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/ejcts\/ezab175","volume":"60","author":"R Lorusso","year":"2021","unstructured":"Lorusso R, Jiritano F, Roselli E, Shrestha M, Folliguet T, Meuris B, et al. Perioperative platelet reduction after sutureless or stented valve implantation: results from the PERSIST-AVR controlled randomized trial. Eur J Cardiothorac Surg. 2021;60(6):1359\u201365.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"2755_CR4","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jtcvs.2016.07.054","volume":"152","author":"F Jiritano","year":"2016","unstructured":"Jiritano F, Cristodoro L, Malta E, Mastroroberto P. Thrombocytopenia after sutureless aortic valve implantation: comparison between Intuity and Perceval bioprostheses. J Thorac Cardiovasc Surg. 2016;152(6):1631\u20133.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2755_CR5","doi-asserted-by":"publisher","unstructured":"Haeussler A, Ntinopoulos V, Rings L, Papadopoulos N, Hoti G, Fleckenstein P et al. Thrombocytopenia after implantation of the perceval, intuity, and sapien aortic valve prostheses. Thorac Cardiovasc Surg. 2023;71(7):550\u20136. https:\/\/doi.org\/10.1055\/s-0042-1757893.","DOI":"10.1055\/s-0042-1757893"},{"issue":"3","key":"2755_CR6","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1532\/hsf.1324","volume":"18","author":"TB Albacker","year":"2015","unstructured":"Albacker TB. Thrombocytopenia associated with perceval sutureless aortic valve replacement in elderly patients: a word of caution. Heart Surg Forum. 2015;18(3):E93\u20137.","journal-title":"Heart Surg Forum"},{"issue":"2","key":"2755_CR7","first-page":"340","volume":"51","author":"O Stanger","year":"2017","unstructured":"Stanger O, Grabherr M, Gahl B, Longnus S, Meinitzer A, Fiedler M, et al. Thrombocytopaenia after aortic valve replacement with stented, stentless and sutureless bioprostheses. Eur J Cardiothorac Surg. 2017;51(2):340\u20136.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2755_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2019.07.056","volume":"296","author":"F Jiritano","year":"2019","unstructured":"Jiritano F, Santarpino G, Serraino GF, ten Cate H, Matteucci M, Fina D, et al. Peri-procedural thrombocytopenia after aortic bioprosthesis implant: a systematic review and meta-analysis comparison among conventional, stentless, rapid-deployment, and transcatheter valves. Int J Cardiol. 2019;296:43\u201350.","journal-title":"Int J Cardiol"},{"issue":"6","key":"2755_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1253\/circj.CJ-19-0875","volume":"84","author":"S Takahashi","year":"2020","unstructured":"Takahashi S, Yokoyama N, Watanabe Y, Katayama T, Hioki H, Yamamoto H, et al. Predictor and mid-term outcome of clinically significant thrombocytopenia after transcatheter aortic valve selection. Circ J. 2020;84(6):1020\u20137.","journal-title":"Circ J"},{"issue":"4","key":"2755_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.21037\/acs-2020-surd-23","volume":"9","author":"M Glauber","year":"2020","unstructured":"Glauber M, Miceli A, di Bacco L. Sutureless and rapid deployment valves: implantation technique from A to Z-the Perceval valve. Ann Cardiothorac Surg. 2020;9(4):330\u201340. https:\/\/doi.org\/10.21037\/acs-2020-surd-23. PMID: 32832417; PMCID: PMC7415689.","journal-title":"Ann Cardiothorac Surg."},{"issue":"3","key":"2755_CR11","first-page":"394","volume":"19","author":"AHM van Straten","year":"2010","unstructured":"van Straten AHM, Hamad MAS, Berreklouw E, ter Woorst JF, Martens EJ, Tan MESH. Thrombocytopenia after aortic valve replacement: comparison between mechanical and biological valves. J Heart Valve Dis. 2010;19(3):394\u20139.","journal-title":"J Heart Valve Dis"},{"key":"2755_CR12","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0003-4975(98)00749-8","volume":"66","author":"A Weerasinghe","year":"1998","unstructured":"Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg. 1998;66:2145.","journal-title":"Ann Thorac Surg"},{"key":"2755_CR13","unstructured":"Edwards Lifesciences. Magna Ease valve. Available from: https:\/\/www.edwards.com\/gb\/devices\/heart-valves\/aortic-pericardial. Accessed 2 Apr 2024."},{"issue":"6","key":"2755_CR14","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jtcvs.2016.07.066","volume":"152","author":"A Miceli","year":"2016","unstructured":"Miceli A. Tissue valve, nitinol stent or storage solution? The mystery still goes on. J Thorac Cardiovasc Surg. 2016;152(6):1633\u20134. Available from: https:\/\/www.clinicalkey.es\/playcontent\/1-s2.0-S0022522316309102.","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"6","key":"2755_CR15","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jtcvs.2016.07.054","volume":"152","author":"F Jiritano","year":"2016","unstructured":"Jiritano F, Cristodoro L, Malta E, Mastroroberto P. Thrombocytopenia after sutureless aortic valve implantation: Comparison between Intuity and Perceval bioprostheses. J Thorac Cardiovasc Surg. 2016;152(6):1631\u20133. Available from: https:\/\/www.clinicalkey.es\/playcontent\/1-s2.0-S0022522316308741.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"2755_CR16","unstructured":"Sena A, Ferreira R, Nobre M, Ferreira H, Junqueira N, Velho T et al. Platelet count drop after rapid deployment aortic valve implantation. Rev Port Cir Cardiotorac Vasc. 2020;27(2):91\u20136.\u00a0"},{"issue":"4","key":"2755_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1510\/icvts.2007.169326","volume":"7","author":"C Yerebakan","year":"2008","unstructured":"Yerebakan C, Kaminski A, Westphal B, Kundt G, Ugurlucan M, Steinhoff G, et al. Thrombocytopenia after aortic valve replacement with the Freedom Solo stentless bioprosthesis. Interact Cardiovasc Thorac Surg. 2008;7(4):616\u201320. Available from: http:\/\/icvts.ctsnetjournals.org\/cgi\/content\/abstract\/7\/4\/616.","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"2755_CR18","doi-asserted-by":"crossref","unstructured":"Shabalovskaya S, van Humbeeck J. 9 - Biocompatibility of Nitinol for biomedical applications. In: Yoneyama T, Miyazaki S, editors. Woodhead Publishing; 2009. p. 194\u2013233. (Shape Memory Alloys for Biomedical Applications). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9781845693442500092.\u00a0Accessed 2 Apr 2024.","DOI":"10.1533\/9781845695248.1.194"},{"issue":"2","key":"2755_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0037-1614998","volume":"79","author":"FM Pulcinelli","year":"1998","unstructured":"Pulcinelli FM, Sebastiani S, Pesciotti M, Pignatelli P, Gazzaniga PP, Daniel JL. Nickel enhances collagen-induced platelet activation acting by increasing the organization of the cytoskeleton. Thromb Haemost. 1998;79(2):395\u20139.","journal-title":"Thromb Haemost"},{"issue":"6","key":"2755_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/00984100150501169","volume":"62","author":"CY Chen","year":"2001","unstructured":"Chen CY, Lin TH. Effects of nickel chloride on human platelets: enhancement of lipid peroxidation, inhibition of aggregation and interaction with ascorbic acid. J Toxicol Environ Health A. 2001;62(6):431\u20138.","journal-title":"J Toxicol Environ Health A"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02755-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-02755-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02755-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:38:16Z","timestamp":1713242296000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-02755-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2755"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-02755-2","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"3 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for ethical approval was waived by the research and ethics office at Royal Brompton and Harefield Trust, given the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The last author, Mr George Asimakopoulos is a proctor for the implantation of the Perceval valve.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}